Accessibility helpSkip to navigationSkip to contentSkip to footer

Cookies on FT Sites

We use cookies for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.

Accept & continue
Manage cookies
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign InmyFT
  • Home
  • World
    Sections
    • World Home
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
    Most Read
    • Crypto collapse reverberates widely among black American investors
    • UK faces first national train drivers’ strike in 27 years
    • Downing Street says Boris Johnson forgot he was briefed about disgraced MP Chris Pincher
    • Military briefing: how close is Russia to taking Donbas after the fall of Luhansk?
    • Bank of England warns UK economic outlook has ‘deteriorated markedly’
  • US
    Sections
    • US Home
    • US Economy
    • US Companies
    • US Politics & Policy
    Most Read
    • Crypto collapse reverberates widely among black American investors
    • How the man behind the Apple Store presided over a Spac catastrophe
    • Michael Lewis: ‘The thing that really works for Trump is: the system’s rigged’
    • Police detain ‘person of interest’ after deadly July 4 shooting in Chicago suburb
    • US bond market flashes warning signal of economic slowdown
  • Companies
    Sections
    • Companies Home
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
    Most Read
    • Warren Buffett-backed Chinese group BYD overtakes Tesla in global electric vehicle sales
    • KPMG’s business in UAE split by partner infighting and coup attempt
    • How the man behind the Apple Store presided over a Spac catastrophe
    • EY boosts accountancy title inflation by dubbing senior staff ‘partner’
    • BA flight cancellations and refuelling strikes set to bring more travel chaos
  • Tech
  • Markets
    Sections
    • Markets Home
    • Alphaville
    • Markets Data
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
    • ETF Hub
    • Cryptocurrencies
    Most Read
    • Live news updates: Rishi Sunak says ‘standards are worth fighting for’
    • US bond market flashes warning signal of economic slowdown
    • Foreign investors dump record $33bn of Indian stocks since October
    • A soft landing is becoming a distant dream
    • Bundesbank boss warns against ‘fatal’ assumptions in ECB crisis tool
  • Climate
  • Opinion
    Sections
    • Opinion Home
    • Columnists
    • The FT View
    • The Big Read
    • Lex
    • Obituaries
    • Letters
    Most Read
    • Erdoğan is an infuriating but indispensable ally
    • Cryptocurrencies are not the new monetary system we need
    • Why groupthink might be a good thing after all
    • What to wear to the office when it’s too hot to wear anything
    • This is the endgame for Boris Johnson — but it may not be quick
  • Work & Careers
    Sections
    • Work & Careers Home
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
    Most Read
    • Michael Lewis: ‘The thing that really works for Trump is: the system’s rigged’
    • Meet the founders with the boomerang factor
    • British Rail: A New History — a timely reminder of how to run a railway
    • How can I move from being a specialist police detective to financial services?
    • Pop-up leaders and flexible staff are ready for a new crisis
  • Life & Arts
    Sections
    • Life & Arts Home
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
    Most Read
    • What to wear to the office when it’s too hot to wear anything
    • Swimsuits to make a splash in 
    • Rule, Nostalgia — a sharp new history of longing for the good old days
    • Life on the idyllic Swedish island where WW3 could start
    • String theory: the evolution of the tennis racket
  • HTSI
  1. Companies
  2. Health
  • Health Care
  • Pharmaceuticals
MenuSearch
  • Home
  • World
  • US
  • Companies
  • Tech
  • Markets
  • Climate
  • Opinion
  • Work & Careers
  • Life & Arts
  • HTSI
Financial Times
SubscribeSign In

Your guide to a disrupted world

Start a 4-week trial

Health sector

Add to myFT Digest

Add this topic to your myFT Digest for news straight to your inbox

  • Tuesday, 5 July, 2022
    CureVac GmbH
    CureVac sues BioNTech over mRNA patents

    Pharma group seeks compensation from Covid vaccine maker for alleged IP infringements

  • Tuesday, 5 July, 2022
    Annie Sparrow
    Russia is waging war on Ukrainian healthcare

    Attacks on hospitals and medical personnel are part of a wider strategy of displacement

  • Monday, 4 July, 2022
    Amy Kazmin
    Overturning Roe will deny women life-saving treatment for late miscarriages like my own

    Campaigners in the US and Malta are protesting against laws that prevent doctors inducing abortion even in dangerous circumstances

  • Sunday, 3 July, 2022
    Covid-19 vaccines
    Covid vaccines: how can immune imprinting help experts to rethink jabs?

    More than two years into the pandemic, people have acquired different levels of immunity through infections and shots

  • Friday, 1 July, 2022
    LexHealth Care
    Walgreens: without a sale of Boots, US group needs a health check Premium content

    Owning physical drugstores is not the cash cow it once was

  • Friday, 1 July, 2022
    Covid-19 vaccines
    Oxford BioMedica extends Covid vaccine deal with AstraZeneca

    New three-year contract in place if UK drugmaker continues to manufacture the jab

  • Thursday, 30 June, 2022
    Hedge funds
    Hedge funds scoop up biotech stocks after ‘catastrophic’ declines

    Some managers expect cheaper valuations will fuel M&A activity

  • Tuesday, 28 June, 2022
    Covid-19 vaccines
    FDA panel recommends redesigning Covid vaccine to target Omicron variant

    Change would incorporate genetic material from fast-spreading strain in new boosters

  • Tuesday, 28 June, 2022
    Anjana Ahuja
    Monkeypox makes pledges of pandemic solidarity look hollow

    The global south has once again been abandoned in its quest for vaccines

  • Tuesday, 28 June, 2022
    Boots UK Ltd
    Walgreens halts sale of Boots chain citing tougher financial conditions

    Owner of UK pharmacy and beauty group blames market turmoil for bids below its expectations

  • Tuesday, 28 June, 2022
    Reproductive rights
    Abortion pills in demand after reversal of Roe vs Wade

    Remote providers report a leap in requests as conservative US states roll out a number of restrictions

  • Monday, 27 June, 2022
    Croda International PLC
    US government to invest up to $75mn in new Croda factory

    Washington seeks to expand domestic production of crucial component of mRNA vaccines

  • Monday, 27 June, 2022
    Covid-19 vaccines
    Pause in medication would improve Covid jab response for millions, study shows

    Short break in immune suppression treatment improves antibody production after vaccination while doing little harm

  • Monday, 27 June, 2022
    CareTech Holdings PLC
    CareTech to be taken private by founders in £1.2bn deal

    UK social care provider has benefited from rising demand during the pandemic

  • Saturday, 25 June, 2022
    Covid-19 vaccines
    BioNTech/Pfizer say Omicron-targeting boosters elicit strong immune response

    New vaccine candidates significantly outperform existing Covid jabs at targeting the most prevalent strain

  • Friday, 24 June, 2022
    Roe vs Wade
    US Supreme Court ruling triggers rush of new restrictions on abortion

    Providers of the procedure scramble as Republican-led states enact pre-planned bans while others consider their own moves

  • Friday, 24 June, 2022
    Roe vs Wade
    US business treads cautious line after Supreme Court abortion ruling

    Companies offer to pay travel expenses for procedure but most refrain from taking sides

  • Friday, 24 June, 2022
    The FT ViewThe editorial board
    Living with Covid-19 requires caution, not complacency

    Governments need to plan now for what could be a tough autumn

  • Friday, 24 June, 2022
    Covid-19 vaccines
    Sanofi-GSK Covid vaccine found effective against Omicron

    Pharma companies are hoping to catch up with rivals as they report promising trial results for jab

  • Thursday, 23 June, 2022
    Coronavirus treatment
    UK prepares to include over-50s in autumn Covid booster campaign

    Javid says he asked officials to revise previous plans that would exclude under-65s

  • Thursday, 23 June, 2022
    Coronavirus pandemic
    Flu epidemic risks sweeping China left vulnerable by zero-Covid fixation

    Xi Jinping orders public health policy to prioritise Covid control over all other diseases

  • Wednesday, 22 June, 2022
    Medical science
    Poliovirus detected in London sewage samples

    UK health agency investigating possibility of community transmission says risk to public ‘extremely low’

  • Wednesday, 22 June, 2022
    Moderna
    Moderna calls for approval of two-strain Covid vaccine booster

    US biotech group says shot targeting both first strain and Omicron could help avert ‘large rise’ in cases

  • Wednesday, 22 June, 2022
    Covid-19 vaccines
    UK signs £1bn deal with Moderna for new vaccine centre

    Government seeks to secure domestic jab supply and prepare for future pandemics in deal with Boston biotech

  • Wednesday, 22 June, 2022
    Biotech
    Biotechs face ‘funding Sahara’ as easy money runs dry

    Early-stage drugmakers face difficult decisions as public markets turn hostile

Previous page You are on page 1 Next page

Topics related to Health & pharmaceuticals

Useful links

Support

View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

Legal & Privacy

Terms & ConditionsPrivacy PolicyCookiesCopyrightSlavery Statement & Policies

Services

Share News Tips SecurelyIndividual SubscriptionsGroup SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on TwitterFT ChannelsSecondary Schools

Tools

PortfolioToday's Newspaper (ePaper)Alerts HubBusiness School RankingsEnterprise ToolsNews feedNewslettersCurrency Converter

Community & Events

FT CommunityFT LiveFT ForumsFT Board DirectorBoard Director Programme

More from the FT Group

Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2022. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
Financial Times

International Edition

Subscribe for full access
  • Switch to UK Edition
  • Top sections
  • Home
  • World
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
  • US
    • US Economy
    • US Companies
    • US Politics & Policy
  • Companies
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
  • Tech
  • Markets
    • Alphaville
    • Markets Data
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
    • ETF Hub
    • Cryptocurrencies
  • Climate
  • Opinion
    • Columnists
    • The FT View
    • The Big Read
    • Lex
    • Obituaries
    • Letters
  • Work & Careers
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
  • Life & Arts
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
  • Personal Finance
    • Property & Mortgages
    • Investments
    • Pensions
    • Tax
    • Banking & Savings
    • Advice & Comment
    • Next Act
  • HTSI
  • Special Reports
  • FT recommends
  • Lex
  • Alphaville
  • Lunch with the FT
  • FT Globetrotter
  • #techAsia
  • Moral Money
  • FTfm
  • Newsletters
  • Video
  • Podcasts
  • News feed
  • FT Community
    • FT Live
    • FT Forums
    • Board Director Programme
  • myFT
  • Portfolio
  • Today's Newspaper (ePaper)
  • Crossword
  • Our Apps
  • Help Centre
  • Subscribe
  • Sign In